Table 3.
Association analysis of the peripheral CD4+ T-cell compartment with T1D
| Phenotype (gating strategy) | n | Healthy donors | Type 1 diabetes patients | % change (95% CI)a | p value | ||
|---|---|---|---|---|---|---|---|
| n | Mean frequency (95% CI) | n | Mean frequency (95% CI) | ||||
| Cytokine productionb | |||||||
|
IL-21+ memory T cells (% of CD4+) (CD4+ CD45RA− IL21−) |
114 | 53 | 4.88% (4.33, 5.50) | 61 | 5.92% (5.44, 6.44) | 21.9% (5.8, 40.2) | 3.9 × 10−3 |
|
IFN-γ+ memory T cells (% of CD4+) (CD4+ CD45RA− IFN-γ+) |
116 | 54 | 20.12% (17.52, 23.11) | 62 | 16.93% (14.67, 19.52) | −12.1% (−24.0, 1.7) | 0.07 |
|
IL-17+ CCR6+ memory T cells (% of CD4+) (CD4+ CD45RA− CCR6+ IL17+) |
66 | 29 | 3.61% (2.68, 4.86) | 37 | 4.26% (3.25, 5.58) | 28.7% (−0.7, 65.9) | 0.04 |
| CD4+ T follicular helper cell (Tfh) frequencyc | |||||||
|
Tfh (% of CD4+ CD45RA− CXCR5+) (PD-1+ CCR6−) |
62 | 32 | 26.02% (23.86, 28.15) | 30 | 29.89% (27.53, 32.25) | 14.9% (2.9, 26.9) | 0.016 |
The p values for the cytokine production phenotypes were calculated by linear regression, including batch as a covariate, comparing the mean frequency of the assessed cytokine production phenotypes in type 1 diabetes patients and healthy donors matched as closely as possible for age, sex and time of sample preparation
aPercent change and 95% CI of the respective T cell phenotype in type 1 diabetes patients relative to healthy donors
bStatistical tests for the cytokine production phenotypes were performed on log-transformed data because some phenotypes showed a strong right skew. Mean frequencies represent the geometric means obtained from the transformation (Y = exp[Y]) of the log-transformed data (natural log)
cThe p value for the Tfh cell immunophenotyping was calculated using an unpaired two-tailed Student’s t test